A 28-year-old woman with dysgerminoma of the right ovary, FIGO Stage IA, desires future fertility. What is the most appropriate management?
- A Bilateral salpingo-oophorectomy with total hysterectomy to prevent recurrence
- B Right salpingo-oophorectomy with full staging; observe without adjuvant chemotherapy ✓
- C Right salpingo-oophorectomy followed by three cycles of BEP chemotherapy
- D Fertility-sparing surgery followed by whole-abdominal radiotherapy
Explanation
Stage IA dysgerminoma has an excellent prognosis (>95% 5-year survival) with unilateral salpingo-oophorectomy alone. Adjuvant chemotherapy (BEP) is NOT required for Stage IA disease because even relapse can be salvaged with chemotherapy with >90% cure rates. Bilateral surgery would compromise fertility unnecessarily. Radiotherapy is now largely abandoned for dysgerminoma due to chemosensitivity and fertility-preservation concerns. Comprehensive surgical staging (peritoneal washings, omentectomy, lymph nodes) should accompany the procedure.
Reference: Shaw's Textbook of Gynaecology, 17th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.